MEDICA 2018: automated tumor diagnosis
Whether or not a tumor has already spread in the organism to form metastases can be determined by lymph node diagnosis. A cross-disciplinary team of scientists from the Fraunhofer Institutes IPA, IIS and ITEM has now optimized and automated this diagnostic method.
The new “High-throughput diagnostic system for tissue-based personalized tumor therapy using lymph nodes as an example,” LyDia HD in short, enables detection of all tumor cells in a lymph node tissue sample. This is not possible with the method that is normally used at present. Due to the automation, the new LyDia HD diagnosis is not only more accurate, but also faster and more cost effective than the methods so far in use. In addition, it provides important information about the types of cells, thereby helping physicians select the most appropriate medication for a particular patient. An important precondition for personalized medicine in the future can thus be met with the new system.